What do an online jeweler, an Australian care provider and a German healthcare giant have in common? A spot in Bain Capital’s ever-growing private equity portfolio—or at least rumors thereof.
Investing alongside Bow Street and Adama Partners, the firm has completed its take-private buyout of online jewelry retailer Blue Nile for $40.75 per share, or about $500 million. In a separate deal, Bain Capital has agreed to buy Craigcare, an operator of elderly care homes in Australia, for somewhere between A$50 million and A$100 million, according to reports from Down Under.
Finally, the firm has been tabbed as the mystery bidder in the auction for German generic drugs business Stada, with Reuters reporting a €3.6 billion bid from Bain Capital. Firms including Cinven and Advent International have been widely reported to be the other leading contenders.